Construction and Analysis of a Risk Prediction Model for Acute Myocardial Infarction Based on Spatiotemporal Heterogeneous Data

Acute myocardial infarction (AMI), as the leading cause of death among cardiovascular diseases, has its diagnosis and treatment efficiency directly affecting survival. Although the current diagnosis and treatment system has significantly improved in-hospital outcomes, delays in seeking medical care due to patients' insufficient awareness and out-of-hospital deaths are common, representing the biggest bottleneck in improving diagnostic and treatment capabilities. This study takes intelligent-assisted diagnosis of AMI as the entry point and proposes a technical approach that combines a deep learning algorithm based on 12-lead electrocardiograms with wearable monitoring devices. By utilizing morphological feature extraction and deep learning models, it aims to achieve early identification and warning of AMI. The study plans to build a multi-center AMI long-term follow-up cohort covering the Beijing area based on spatiotemporal heterogeneous data. By integrating and forming a precise high-risk cohort of 3,000 acute myocardial infarction cases, it seeks to construct an AMI risk prediction model that combines deep learning with a retrieval-augmented generative expert system, breaking through bottlenecks in ECG recognition and temporal prediction, enhancing model generalization and transferability. Ultimately, it will support the application of wearable devices, shorten pre-hospital delays, achieve early warning and precise diagnosis of AMI, reduce reinfarction and cardiac-related mortality, and carry significant clinical and public health importance.

Study Overview

• Status: Not yet recruiting
• Conditions: Acute Myocardial Infarction (AMI)
• Intervention / Treatment: Diagnostic test: Acute Myocardial Infarction Risk Prediction Model

• Study Type: Observational
• Enrollment (Estimated): 3000

Contacts and Locations

• Study Contact: Name: Yan Yan; Phone Number: +861064456782; Email: eva3321@sina.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Probability Sample

Study Population

The integrated team covers preliminary cohorts with multi-dimensional data, including multi-center clinical, imaging, and sample information (total cases >300,000). Based on cohort quality and risk factors, multi-dimensional data is collected on high-risk patients (such as those with previous myocardial infarction, multi-vessel disease, CKD, DM, etc.) to complete the data. The primary endpoint is the time to the first occurrence of acute myocardial infarction within one year after enrollment. Follow-up points are set according to myocardial reinfarction characteristics and needs, and a long-term follow-up plan is formulated (including: frequency of follow-up, follow-up methods, laboratory tests, wearable device data, etc.). Regular follow-up and supplementation of multi-modal data are conducted, ultimately completing a 3,000-case multi-dimensional AMI cohort.

Description

Inclusion Criteria:

1. High-risk population for acute myocardial infarction, previously confirmed by cardiac imaging to have coronary artery disease and at least one of the following risk factors:

   • Multivessel coronary artery disease (defined as ≥50% stenosis in at least 2 coronary artery regions, including the left main coronary artery)
   • Previous myocardial infarction
   • Patients with diabetes currently undergoing glucose-lowering treatment
   • Chronic kidney disease (CKD) defined as an estimated glomerular filtration rate <60 mL/min/1.73 m² with a known history of chronic kidney disease or biomarkers indicating chronic kidney damage
   • Peripheral artery disease, defined as any of the following: ankle-brachial index <0.85; >50% stenosis in lower limb arteries confirmed by angiography (invasive or non-invasive) or duplex ultrasound; limb amputation, peripheral artery bypass, or vascular surgery (such as angioplasty or endarterectomy) secondary to ischemia
2. Age ≥18 years
3. Ability to understand and comply with the study protocol and sign the informed consent form

Exclusion Criteria:

1. Researchers consider diseases or conditions that are not suitable for participation in this study (such as mental illness, significant cognitive impairment, neurodegenerative diseases, advanced malignant tumors) or situations (such as inability to communicate well with researchers in the local language, unwillingness to comply with study procedures/instructions, inability to understand study-specific training, physically fragile and vulnerable subjects).
2. Participation in a clinical trial involving drugs or devices within 3 months prior to enrollment.
3. Women who are pregnant, planning to become pregnant, or breastfeeding.
4. Known life-threatening diseases with an expected survival of less than 12 months.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
The time of the first occurrence of acute myocardial infarction (AMI) within 1 year after enrollment.	1 year

Collaborators and Investigators

• Sponsor: Beijing Anzhen Hospital

Study record dates

Study Major Dates

• Study Start (Estimated): March 25, 2026
• Primary Completion (Estimated): May 31, 2026
• Study Completion (Estimated): May 31, 2027

Study Registration Dates

• First Submitted: March 23, 2026
• First Submitted That Met QC Criteria: March 23, 2026
• First Posted (Actual): March 27, 2026

Study Record Updates

• Last Update Posted (Actual): March 27, 2026
• Last Update Submitted That Met QC Criteria: March 23, 2026
• Last Verified: March 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: KS2026022

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO